- Home
- PRPL vs ANVS Comparison
PRPL vs ANVS Comparison
Compare PRPL & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PRPL | ANVS |
|---|---|---|
| Founded | 2010 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Home Furnishings | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 76.9M | 111.3M |
| IPO Year | 2015 | 2019 |
Fundamental Metrics
Financial Performance| Metric | PRPL | ANVS |
|---|---|---|
| Price | $0.71 | $1.99 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | $1.00 | ★ $13.50 |
| AVG Volume (30 Days) | 210.4K | ★ 359.7K |
| Earning Date | 05-05-2026 | 03-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 22.22 | ★ 39.39 |
| EPS | ★ 0.45 | N/A |
| Revenue | ★ $487,877,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $12.69 | N/A |
| P/E Ratio | $1.36 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.56 | $1.11 |
| 52 Week High | $1.26 | $5.50 |
Technical Indicators
Market Signals| Indicator | PRPL | ANVS |
|---|---|---|
| Relative Strength Index (RSI) | 52.60 | 33.25 |
| Support Level | $0.66 | $1.97 |
| Resistance Level | $0.74 | $2.99 |
| Average True Range (ATR) | 0.05 | 0.22 |
| MACD | -0.00 | -0.05 |
| Stochastic Oscillator | 83.75 | 1.89 |
Price Performance
Historical ComparisonAbout PRPL Purple Innovation Inc.
Purple Innovation Inc is a comfort innovation company. The company designs, manufactures and sells a range of comfort technology offerings, including mattresses, a pillow, cushions, sheets, bed platforms and other products. The Company has one reportable segment that operates an omni-channel distribution which allows the Company to offer a seamless shopping experience to its customers across multiple sales channels. It sells its products through its direct-to-consumer e-commerce channels, retail brick-and-mortar wholesale partners, Purple showrooms, and third-party online retailers.
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.